FabiFlu: Anti-Covid drug now top-selling pharma brand
Anti-viral drug FabiFlu, which is used in treating COVID-19, has registered a 600 percent jump in sales for the month of April and is now the largest selling pharma brand in India for the first time.
May 11, 2021, 16:21 PM IST
Glenmark defends price of its COVID-19 drug favipiravir version
Glenmark also denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients.
Jul 21, 2020, 12:20 PM IST
DCGI queries Glenmark Pharma on claims of FabiFlu use for COVID-19 patients with comorbidities
India's drug regulator DCGI has sought a clarification from Glenmark Pharmaceuticals over its alleged "false claims" about the use of anti-viral FabiFlu on COVID-19 patients with comorbidities.
Jul 19, 2020, 20:38 PM IST
